Summary:
Sentral Clinical Research Services is currently seeking volunteers between 18 and 65 years of age with Type 1 Diabetes to take part in a new clinical research study, The INSTRIDE 1 Study.
The study will last for 66 weeks with 22 study visits (six of these may be conducted by telephone rather than at the study center).
To learn more about participating in the INSTRIDE 1 Study, please contact Sentral Clinical Research Services.
Qualified Participants Must:
Be between 18 and 65 years of age
Be diagnosed with Type 1 Diabetes
Be taking Lantus® (insulin glargine) for at least 3 months
Qualified Participants May Receive:
All study medications and study-related healthcare will be provided at no cost
to you.